Emerging data seem to support an effect of chemotherapy on PD-L1 expression in NSCLC [7,8] and increasing evidence indicates that PD-L1 expression may be regulated by both intrinsic and extrinsic mechanisms in different tumor types [9,10]. This evidence concerns the gene CD274 and neoplasm.